Eli Lilly
LLY
LLY
3,877 hedge funds and large institutions have $678B invested in Eli Lilly in 2025 Q1 according to their latest regulatory filings, with 246 funds opening new positions, 1,776 increasing their positions, 1,397 reducing their positions, and 166 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
4.71% more ownership
Funds ownership: 82.13% → 86.83% (+4.7%)
0% more funds holding
Funds holding: 3,871 → 3,877 (+6)
7% less call options, than puts
Call options by funds: $9.22B | Put options by funds: $9.88B
Holders
3,877
Holding in Top 10
389
Calls
$9.22B
Puts
$9.88B
Top Buyers
| 1 | +$41.3B | |
| 2 | +$4.12B | |
| 3 | +$4.11B | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$941M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$894M |
Top Sellers
| 1 | -$2.23B | |
| 2 | -$1.71B | |
| 3 | -$1.63B | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.43B |
| 5 |
JPMorgan Chase & Co
New York
|
-$1.19B |
